Figure 2From: L-histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxinHistidine appears to act by inhibiting the ATX LPLD activity. The modified Boyden chamber motility assays with A2058 cells are described in Materials and Methods. In these assays, pre-incubations were in DBA media for 3 hr at 37°C. A) L-histidine decreases formation of a chemoattractant by ATX. Shown concentrations of L-histidine were pre-incubated with ATX plus 200 nM LPC, then ATX was heat-inactivated prior to utilizing the resulting mixture as chemoattractant in a motility assay (solid black bars). Data are compared to identical treatments of 100 nM LPA as chemoattractant (white bars). B.) L-histidine decreases formation of a motility inhibitor by ATX. Shown concentrations of L-histidine were pre-incubated with (ATX + 100 nM SPC + 100 nM LPA). ATX was heat inactivated prior to utilizing the mixture as chemoattractant. Controls are shown for comparison: DBA, 100 nM LPA, (100 nM LPA + 100 nM S1P), (100 nM LPA + 100 nM SPC). All data are shown as Mean ± SEM. Means were analyzed utilizing the ANOVA/Tukey's post-test (GraphPad Prism, San Diego, CA): * (p < 0.001) for histidine-treated vs. the appropriate untreated control.Back to article page